Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

21. März 2008 07:00 ET | Quelle: Encysive Pharmaceuticals Inc.

UPDATE -- Encysive Pharmaceuticals Reports Fourth Quarter and Year End 2007 Financial Results

HOUSTON, March 21, 2008 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) previously reported the filing of its annual report on Form 10-K for the year ended December 31, 2007. This...
17. März 2008 17:19 ET | Quelle: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Reports Fourth Quarter and Year End 2007 Financial Results

HOUSTON, March 17, 2008 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced the filing of its annual report on Form 10-K for the year ended December 31, 2007. This filing...
22. Februar 2008 07:00 ET | Quelle: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Announces Date Change for Reporting 2007 Year-End Financials

HOUSTON, Feb. 22, 2008 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced that the Company has changed the date for reporting its fourth quarter and year end 2007...
31. Januar 2008 02:00 ET | Quelle: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Launches THELIN (Sitaxentan Sodium) in Sweden

HOUSTON, Jan. 31, 2008 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced the commercial availability of THELIN(r)(1) (sitaxentan sodium(2)) 100 mg tablets in Sweden....
14. Januar 2008 02:00 ET | Quelle: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Launches THELIN (sitaxentan sodium) in Belgium and Luxembourg

HOUSTON, Jan. 14, 2008 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced the commercial availability of THELIN(r)(1) (sitaxentan sodium(2)) 100 mg tablets in Belgium and...
28. Dezember 2007 16:01 ET | Quelle: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Announces Patent Infringement Lawsuit Against Barr Laboratories

HOUSTON, Dec. 28, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced that Mitsubishi Chemical Corporation, the patent holder for Argatroban injections, Mitsubishi...
19. Dezember 2007 16:15 ET | Quelle: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Receives Delisting Warning Letter From NASDAQ

HOUSTON, Dec. 19, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) announced that today it received a delisting warning letter from the Nasdaq Stock Market, notifying it that the...
14. Dezember 2007 07:15 ET | Quelle: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Provides THELIN Sales Guidance for 2007 and 2008

HOUSTON, Dec. 14, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced guidance for sales of THELIN(r)(1) (sitaxentan sodium(2)) 100 mg tablets for 2007 and 2008....
26. November 2007 02:00 ET | Quelle: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Launches Thelin (sitaxentan sodium) in Italy

HOUSTON, Nov. 26, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced the commercial availability of THELIN(r)(1) (sitaxentan sodium(2)) 100 mg tablets in Italy for...
05. November 2007 17:00 ET | Quelle: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Announces Presentation of Sitaxsentan Data in Eisenmenger Syndrome At AHA Meeting

HOUSTON, Nov. 5, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals, Inc. (Nasdaq:ENCY) today announced that open label observational data from Columbia University suggests that sitaxsentan (THELIN), a...

Nächste Seite